News more

  • Foley Hoag Congratulates Seth D. Jaffe for Being Ranked "Top Environmental Lawyer in Boston" by Best Lawyers  [Read More]
  • Medicare Regulatory Attorney Jayson Slotnik Joins Foley Hoag's Life Sciences Practice  [Read More]
  • Foley Hoag Welcomes Julia Huston as Partner, Expands Intellectual Property Focus  [Read More]
  • Foley Hoag Partner Vickie L. Henry Named Chair of the Commercial Litigation Committee of the DRI - Voice of the Defense Bar  [Read More]
  • Noted International Arbitration Lawyer Mark Clodfelter Joins Foley Hoag  [Read More]

Publications more

  • EEC Perspectives - November 2009 [Read More]
  • Hedge Funds Join “the CEO’s Brother-in-Law” as the Target of Insider Trading Cases [Read More]
  • Congress Amends the FMLA To Provide Additional Family Military Leave  [Read More]
  • FDA Deviations In Menaflex Knee Device Clearance [Read More]
  • Commercializing Stem Cell-Based Therapies: Meeting NIH and FDA Requirements [Read More]
  • Massachusetts and Federal Statutory Limitations on Liability for Charitable Organizations and their Directors or Trustees, Employees and Volunteers [Read More]

Events more

December 1, 2009 Changing Investment Landscape 2009-2010: The Challenge for Investors and Entrepreneurs  [Read More] Emerging Enterprise Center at Foley Hoag
Waltham, MA
December 1, 2009 Angel & Venture Term Sheets Deep-Dive Lunch  [Read More] Emerging Enterprise Center at Foley Hoag
Waltham, MA
December 1, 2009 Acquiring Customers [Read More] Emerging Enterprise Center at Foley Hoag
Waltham, MA
December 2, 2009 The Art and Science of Negotiation  [Read More] Emerging Enterprise Center at Foley Hoag
Waltham, MA
December 4, 2009 14th New England Restructuring Roundtable [Read More] Foley Hoag LLP (Boston Office)
Boston, MA

Client Successes

  • Pluromed, Inc.
    Foley Hoag handles the intellectual property needs of medical device company Pluromed, Inc., a Woburn, Massachusetts-based provider of products addressing a broad surgery market, including cardiac and vascular surgery, prostate, kidney and liver surgery, plastic/reconstructive surgery, trauma/battlefield applications and the treatment of kidney stones. Recently, Pluromed entered into an agreement with Boston Scientific to distribute its BackstopTM product, a device used in ureteroscopic kidney stone management procedures. View the company press release here. BackstopTM  is based on Pluromed’s proprietary Rapid Transition PolymersTM that are liquid at low temperature and transition to a gel at body temperature.  The product may be used in minimally-invasive kidney stone removal procedures known as intracorporeal lithotripsy.  BackStopTM offers the potential to reduce operating time and complexity, and improve “stone free” rates in patients receiving intracorporeal lithotripsy.  Foley Hoag handled the patent portfolio relating to the product, as well as advised on various terms of the alliance. The firm has represented Pluromed in intellectual property matters since the company was founded in 2003. 

     [Read More]
  • HyperBranch Medical Technology, Inc.
    For our client HyperBranch Medical Technology, Inc., a leader in the field of polymeric medical sealants, we assisted with the intellectual property portfolio strategy in connection with obtaining CE Mark designation for the company’s OcuSeal product. OcuSeal is a liquid ocular bandage used to stabilize ocular wounds following surgical or non-surgical trauma. CE Marking denotes that a product complies with all requirements of European health, safety, and environmental product legislation, and is an important step in bringing products to market overseas. HyperBranch began its research in 2004 with the objective to develop strong enough polymer sealants to ultimately replace sutures that would be easy to use, and would not interfere with natural healing. The Durham, North Carolina medical device company has also, been developing advanced surgical sealants for dura (brain), pleural (lung) and hernia mesh fixation. These products are all at various stages of clinical and pre-clinical development. Read more about HyperBranch Medical Technology here. [Read More]